Preliminary observations from the trial were presented at the Global Embolization Symposium and Technologies US (GEST US meeting, 1–4 May, San Francisco, USA) and show increased tumour penetration with the Surefire system.
Interventional radiology techniques are widely performed and useful in liver metastases from neuroendocrine tumours, but the level of scientific proof is paradoxically low, especially when considering that these techniques are used in patients with cancer, write Maxime Ronot and Valérie Vilgrain.
The US$415 million cash acquisition is expected to strengthen Boston Scientific’s peripheral interventions business and accelerate growth in peripheral atherectomy and thrombectomy categories.
May 30, 2014—Veryan Medical, Ltd. announced that full 2-year data from the MIMICS study were presented at the 15th annual New Cardiovascular Horizons (NCVH) conference in New Orleans, Louisiana.
Seeking a second and third opinion reduced the number of hysterectomies carried out to treat uterine fibroids, according to a single-center study published in the open access Journal of Therapeutic Ultrasound.
A new genetic "signature" to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna heard.
Shrinking the prostate without surgery can provide long-term relief to men with this common condition that causes annoying symptoms, such as frequent trips to the bathroom, suggests a study of nearly 500 men. According to research being presented at the Society of Interventional Radiology s 39th Annual Scientific Meeting, 72 percent of men experienced symptom improvement three years after having a new, minimally invasive, image-guided treatment performed by interventional radiologists called prostate artery embolization (PAE).
Imaging of the coronary arteries with computed tomography (CT) angiography provides an accurate assessment of arterial plaque and could have a dramatic impact on the management of diabetic patients who face a high risk of heart attacks and other cardiovascular events, according to a new multicenter study published online in the journal Radiology.
In a report of their proof of principle study in the Journal of Urology, researchers from the University of Tampere describe how the "eNose" successfully differentiated between prostate cancer and benign prostatic hyperplasia (BPH) by analyzing the "smell print" of the headspace of a urine sample (the air immediately above the urine).
Patients with peripheral arterial disease in the upper leg experienced significantly better outcomes at 12 months after treatment with the In.Pact Admiral drug-coated balloon (Medtronic) than with standard balloon angioplasty, according to a landmark clinical study reported for the first time at the Charing Cross Symposium (5–8 April, London, UK)
TriReme Medical announced in a company release that the first three patients were enrolled in a clinical study of its unique drug-coated Chocolate percutaneous transluminal angioplasty balloon. Andrew Holden, co-principal investigator of the study, performed these procedures at Auckland City Hospital, in Auckland, New Zealand.
Metactive Medical presented new nonclinical data on one of its investigational devices at the Society of Interventional Radiology’s (SIR) Annual Scientific Meeting. The presentation focused on the company’s device that addresses the cerebral aneurysm market
A study, published in the Journal of Vascular and Interventional Radiology, highlights the benefits of the transradial approach to treat uterine fibroids and investigators find that this technique could be a “game changer” for image-guided minimally invasive treatments.
Surefire Medical has announced that the COSY clinical trial (Coiling vs. Surefire infusion system in Y90) showed significant reductions in fluoroscopy time, procedure time, radiation dose and contrast dose when using the Surefire Infusion System without coiling.
Sirtex and Guerbet have announced that the two companies are entering into a collaboration to advance research in primary and secondary metastatic liver cancer.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos